¥È¥Ã¥×¥Ú¡¼¥¸

Åìµþ»ü·Ã°å²ÊÂç³ØƱÁë²ñ

ºÇ¿·¾ðÊó


2022ǯ12·î25Æü¡¡üⶶ·ò½õ¶µ¡ÊÊ¿19¡Ë
ÎáÏÂ4ǯÅÙÆüËܼþ»º´ü¡¦¿·À¸»ù°å³ØÎ×¾²¸¦µæAward¼õ¾Þ


¡¡»ºÉؿͲʳعֺ¤Îüⶶ·ò·¯¤¬¡¢ÆüËܼþ»º´ü¡¦¿·À¸»ù°å³Ø²ñ¤¬Áª¹Í¤¹¤ëÎáÏ»ÍǯÅ٤ΡÖÆüËܼþ»º´ü¡¦¿·À¸»ù°å³Ø²ñÎ×¾²¸¦µæ£Á£÷£á£ò£ä¡×¤ËÁª¹Í¤µ¤ì¤¿¡£ËÜ£Á£÷£á£ò£ä¤Ï¡¢¿·¤¿¤Ê¿»ÜÀ߶¦Æ±¤ÎÎ×¾²»î¸³¤ä¼À´µ¥ì¥¸¥¹¥È¥ê¤Î´ë²è¡¦Î©¤Á¾å¤²¤ò»Ù±ç¤¹¤ë¤³¤È¤Ë¤è¤Ã¤Æ¡¢¼þ»º´ü¿·À¸»ùÎΰè¤ÎÎ×¾²¸¦µæ¤Î³èÀ­²½¤ò¿Þ¤ê¡¢Åö³ºÎΰè¤Ë¤ª¤±¤ë´µ¼Ô¡¦²È²¤Îͽ¸å¤ä£Ñ£Ï£Ì¸þ¾å¤Ë¹×¸¥¤¹¤ë¤³¤È¤òÌÜŪ¤È¤·¤Æ¤¤¤ë¡£Â¿¿ô¤Î±þÊç¤ÎÃ椫¤é¡¢º£²ó¡¢¡Ö̵¿¯½±ÅªÂÛ»ùRHD¥¸¥§¥Î¥¿¥¤¥Ô¥ó¥°µ»½Ñ¤Ë¤è¤ëÂÛ»ù£Ò£è£Ä·ì±Õ·¿¿ÇÃǤÎÂ絬ÌÏ¿»ÜÀ߶¦Æ±¼Â¾Ú¸¦µæ¤È°å»Õ¼çƳ¼£¸³¤Ë¸þ¤±¤¿Á°Êý»ëŪ¥ì¥¸¥¹¥È¥ê¤Î¹½Ãۡפ¬£Á£÷£á£ò£ä¤È¤·¤ÆÁª¹Í¤µ¤ì¤¿¡£
¡¡ÊìÂΤηì±Õ·¿¤¬£Ò£è£Ä±¢À­¤Î¾ì¹ç¡¢ÂÛ»ù·ì±Õ·¿ÉÔŬ¹ç¤ËÂФ¹¤ë¹³ÂλºÀ¸¤òÍÞÀ©¤¹¤ë¤¿¤á¤ËÇ¥¿±£²£¸½µº¢¤ËÊìÂΤ˹³£Ä¥Ò¥ÈÌȱ֥°¥í¥Ö¥ê¥óÅêÍ¿¤ò¹Ô¤¦¤¬¡¢ÂÛ»ù·ì±Õ·¿¤¬£Ò£è£Ä±¢À­¤Î¾ì¹ç¤Ï¤³¤ÎͽËÉÅêÍ¿¤ÏÉÔÍפǤ¢¤ë¡£ËÜ£Á£÷£á£ò£ä¤òÍøÍѤ·¡¢üⶶ·¯¤é¤¬³«È¯¤·¤¿¡¢ÊìÂηìÃæÍ·Î¥³Ë»À¤òÍѤ¤¤¿ÂÛ»ù£Ò£è£Ä·ì±Õ·¿¸¡ººË¡¤¬¡ÊTakahashi K et al.Amplicon S-equencing-Based Noninvasive Fet-al Genotyping f-or RHD-Positive D Antigen-Neg-ative Alleles.Cli-nical Chemistry.2019 Oct ; 65¡Ê£±£°¡Ë£±£³£°£·¡½£±£³£±£¶¡Ë¡¢Â¿¿ô¤ÎÆüËÜ¿Í£Ò£è£Ä±¢À­Ç¥ÉؤòÂоݤȤ·¤Æ¡¢°ÂÄêŪ¤«¤ÄÍ­¸ú¤Ë¼Â»Ü²Äǽ¤«Èݤ«¡¢¤Þ¤¿¡¢£Ò£è£Ä±¢À­Ç¥ÉؤΤ¦¤Á¡¢¼ÂºÝ¤Ë¹³£Ä¥Ò¥ÈÌȱ֥°¥í¥Ö¥ê¥ó¤ÎÅêÍ¿¤¬É¬Íפ⤷¤¯¤ÏÉÔÍפʾÉÎã¿ô¤Ê¤É¤òÄ´ºº¤·¡¢¾­ÍèŪ¤Ê¼ÂÎ×¾²¤Ø¤ÎƳÆþ¤òÌÜŪ¤È¤·¡¢¸¦µæ¤ò¤µ¤é¤Ë¿ä¿Ê¤¹¤ë¤³¤È¤Ë¤Ê¤ë¡£
¡¡¤³¤ÎÁ´¤¯¿·¤·¤¤ÊìÂηì¤òÍѤ¤¤¿Ìµ¿¯½±Åª¤Ê£Ò£è£Ä·ì±Õ·¿¤Î½ÐÀ¸Á°¿ÇÃÇË¡¤¬³ÎΩ¤µ¤ì¤ì¤Ð¡¢£Ò£è£Ä±¢À­Ç¥ÉؤËÂФ¹¤ë¡¢Í½ËÉŪ¤Ê¹³£Ä¥Ò¥ÈÌȱ֥°¥í¥Ö¥ê¥óÅêÍ¿¤Î²óÈò¤ä¡¢°åÎÅ»ñ¸»¤ÎŬÀµ¤Ê±¿ÍѤˤĤʤ¬¤ë¡£¤Þ¤¿¡¢ÆüËܤˤª¤±¤ë¡¡£Ò£è£ÄÉÔŬ¹çÇ¥¿±¤Î´ÉÍý¡¦¼£ÎÅÊýË¡¤òº¬ËÜŪ¤ËÊѤ¨¤ë²ÄǽÀ­¤¬¤¢¤ë¡£¤µ¤é¤ËËܵ»½Ñ¤Ï¡¢Â¾¤Î¿ÇÃǺ¤Æñ¤ÊÂÛ»ù°äÅÁ»Ò¿ÇÃǤˤâ±þÍѤ¬Íưפ˲Äǽ¤Ç¤¢¤ê¡¢Ëܸ¦µæ¤ÇÆÀ¤é¤ì¤ëÃθ«¤Ï£Ò£è£Ä·ì±Õ·¿¸¡ºº¤Ë¤È¤É¤Þ¤é¤Ê¤¤¡£
¡¡º£²ó¤Îüⶶ·¯¤Î¼õ¾Þ¤Ï¡¢ÂÛ»ù¤Ø¤Î̵¿¯½±Åª¤ÊÁ´¤¯¿·¤·¤¤½ÐÀ¸Á°¸¡ºº¤Î¼êË¡¤ò³«È¯¤·¤¿¤³¤È¤¬É¾²Á¤µ¤ì¤¿£Á£÷£á£ò£ä¤Ç¤¢¤ë¡£º£¸å¤Î±×¡¹¤Î³èÌö¤È¤µ¤é¤Ê¤ë¸¦µæ¤ÎȯŸ¤òµ§Ç°¤·¤Æ¤¤¤ë¡£
¡Ê»ºÉؿͲʳعֺ¶µ¼ø¡¡º´Â¼¡¡½¤µ­¡Ë

top